Intermediates for macrocyclic compounds
AssigneeOcera Therapeutics, Inc.
InventorsEric Marsault, Kamel Benakli, Hamid Hoveyda, Mark L. Peterson, Sylvie Beaubien, Luc Oullet, Carl St-Louis, Sophie Beauchemin
Life of this patent
Estimating the term…
Loading patent…
AssigneeOcera Therapeutics, Inc.
InventorsEric Marsault, Kamel Benakli, Hamid Hoveyda, Mark L. Peterson, Sylvie Beaubien, Luc Oullet, Carl St-Louis, Sophie Beauchemin
Estimating the term…
The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: wherein R1, R2, R3, R4, R5, R6, n1, m, p Z1, Z2, and Z3 are as described in the specification. The invention also relates to compounds of formula (I) which are antagonists of the motilin receptor and are useful in the treatment of disorders associated with this receptor and with or with motility dysfunction.
1-12. (canceled)
A process for preparing a compound of formula (G):
A process for using a compound of formula (G):
Dependencies are inferred from the claim text.